Holistic Approach to Ecstasy-induced Atrial Fibrillation in a Young Patient: A Case Report

Authors

  • Syuhaida Shuib Department of Emergency and Trauma, Hospital Tuanku Fauziah, Jalan Tun Abdul Razak, 01000 Kangar, Perlis, Ministry of Health Malaysia, Malaysia
  • Rafeek Ismail Department of Emergency and Trauma, Hospital Sultan Abdul Halim, Bandar Amanjaya, 08000 Sungai Petani, Kedah, Ministry of Health Malaysia, Malaysia

DOI:

https://doi.org/10.31674/mjmr.2023.v07i01.006

Abstract

Stimulants abuse is a global issue. Acute myocardial infarction, heart failure, and arrhythmia have all been linked to stimulants misuse and its synthetic variants but are rather uncommon. Herein, we present a case of a young patient presented with atrial fibrillation that did not respond to digoxin therapy. A suspicion of drug toxicity was later confirmed with a bedside urine screening. Following administration of benzodiazepines, the patient's clinical condition gradually improved, and he was eventually discharged with a prescription of lifelong warfarin. Therefore, patients with a low-to-intermediate risk of coronary artery disease presenting with atypical symptoms may benefit from a full substance use history and urine drug screening to ensure prompt institution of appropriate treatment. 

Keywords:

Amphetamin, Atrial Fibrillation, Benzodiazepines, Substance Abuse

Downloads

Download data is not yet available.

References

Bazmi, E., Mousavi, F., Giahchin, L., Mokhtari, T., & Behnoush, B. (2017). Cardiovascular Complications of Acute Amphetamine Abuse: Cross-sectional study. Sultan Qaboos University Medical Journal, 17(1), e31–e37. https://doi.org/10.18295/squmj.2016.17.01.007

Bonsignore, A., Barranco, R., Morando, A., Fraternali Orcioni, G., & Ventura, F. (2019). MDMA Induced Cardio-toxicity and Pathological Myocardial Effects: A Systematic Review of Experimental Data and Autopsy Findings. Cardiovascular Toxicology, 19(6), 493–499. https://doi.org/10.1007/s12012-019-09526-9

Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F., & Bastos, M.deL. (2012). Toxicity of amphetamines: an update. Archives of Toxicology, 86(8), 1167–1231. https://doi.org/10.1007/s00204-012-0815-5

D'Errico, S. (2021). Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives. Current Neuropharmacology, 19(11), 2038–2048. https://doi.org/10.2174/1570159X19666210412101929

Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007). New insights into the mechanism of action of amphetamines. Annual Review of Pharmacology and Toxicology, 47, 681–698. https://doi.org/10.1146/annurev.pharmtox.47.120505.105140

Frishman, W. H., Del Vecchio, A., Sanal, S., & Ismail, A. (2003). Cardiovascular manifestations of substance abuse: part 2: alcohol, amphetamines, heroin, cannabis, and caffeine. Heart Disease (Hagerstown, Md.), 5(4), 253–271. https://doi.org/10.1097/01.hdx.0000080713.09303.a6

Greene, S. L., Kerr, F., & Braitberg, G. (2008). Review article: amphetamines and related drugs of abuse. Emergency medicine Australasia : EMA, 20(5), 391–402. https://doi.org/10.1111/j.1742-6723.2008.01114.x

Ito, H., Yeo, K. K., Wijetunga, M., Seto, T. B., Tay, K., & Schatz, I. J. (2009). A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse. Clinical Cardiology, 32(6), E18–E22. https://doi.org/10.1002/clc.20367

Katzung, B., Masters, S., & Trevor, A. (2004). Basic & clinical pharmacology. https://doctorlib.info/pharmacology/basic-clinical-pharmacology-13/1.html

Liu, J. F., & Li, J. X. (2018). Drug addiction: a curable mental disorder?. Acta pharmacologica Sinica, 39(12), 1823–1829. https://doi.org/10.1038/s41401-018-0180-x

Meng, G. K. (2017). A Study On Amhetamine Type Stimulant (ATS) Users In Selected States In Malaysia. Universiti Sains Malaysia. Retrieved from http://eprints.usm.my/id/eprint/38749

National Antidrugs Agency Malaysia. (2020). Buku Maklumat Dadah 2020. Kajang, Selangor. https://online.fliphtml5.com/rfypn/smol/#p=1

Nishida, N., Ikeda, N., Kudo, K., & Esaki, R. (2003). Sudden unexpected death of a methamphetamine abuser with cardiopulmonary abnormalities: a case report. Medicine, Science and the Law, 43(3), 267–271. https://doi.org/10.1258/rsmmsl.43.3.267

Radaelli, D., Manfredi, A., Zanon, M., Fattorini, P., Scopetti, M., Neri, M., Frisoni, P., & D'Errico, S. (2021). Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives. Current Neuropharmacology, 19(11), 2038–2048. https://doi.org/10.217/1570159X19666210412101929

Schifano, F., Napoletano, F., Chiappini, S., Guirguis, A., Corkery, J. M., Bonaccorso, S., Ricciardi, A., Scherbaum, N., & Vento, A. (2021). New/emerging psychoactive substances and associated psychopathological consequences. Psychological Medicine, 51(1), 30–42. https://doi.or/10.1017/S0033291719001727

Smets, G., Bronselaer, K., De Munnynck, K., De Feyter, K., Van de Voorde, W., & Sabbe, M. (2005). Amphetamine toxicity in the emergency department. European Journal of Emergency Medicine, 12(4), 193–197. https://doi.org/10.1097/00063110-200508000-00010

Won, S., Hong, R. A., Shohet, R. V., Seto, T. B., & Parikh, N. I. (2013). Methamphetamine-associated cardiomyopathy. Clinical Cardiology, 36(12), 737–742. https://doi.org/10.1002/clc.22195

Published

16-02-2023

How to Cite

Shuib, S., & Ismail, R. . (2023). Holistic Approach to Ecstasy-induced Atrial Fibrillation in a Young Patient: A Case Report. Malaysian Journal of Medical Research (MJMR), 7(1), 25-29. https://doi.org/10.31674/mjmr.2023.v07i01.006

Metrics